Delineation of molecular findings by whole-exome sequencing for suspected cases of paediatric-onset mitochondrial diseases in the Southern Chinese population

Autor: Brian H.Y. Chung, Che-Kwan Ma, Kate L.S. Chan, Shuk-Mui Tai, Anna K.Y. Kwong, Mandy H.Y. Tsang, Rachel Chan, Cheuk-Wing Fung, Jan A.M. Smeitink, Christopher C.Y. Mak, W.K. Chak, Shelia S.N Wong, Sharon T. H. Fung, Thomas Tsoi, Jasmine L.F. Fung, Richard J. Rodenburg, Shun-Ping Wu, Joannie Hui, Kit San Yeung, Victor Chi Man Chan, Mullin H.C. Yu
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Oncology
Mutation rate
Mitochondrial Diseases
lcsh:Medicine
GTP Phosphohydrolases
Mixed Function Oxygenases
Cohort Studies
0302 clinical medicine
Drug Discovery
Child
Exome sequencing
education.field_of_study
Nuclear Proteins
Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]
Homeobox Protein Nkx-2.2
Whole-exome sequencing
Molecular Medicine
Medical genetics
Female
Sodium-Potassium-Exchanging ATPase
Primary Research
China
medicine.medical_specialty
Mitochondrial DNA
lcsh:QH426-470
Mitochondrial disease
Population
Mitochondrial Proteins
03 medical and health sciences
Asian People
Internal medicine
Exome Sequencing
Genetics
medicine
Humans
Genetic Predisposition to Disease
education
Molecular Biology
Homeodomain Proteins
business.industry
Genetic heterogeneity
lcsh:R
Paediatrics
medicine.disease
Human genetics
lcsh:Genetics
030104 developmental biology
Mutation
business
030217 neurology & neurosurgery
Transcription Factors
Zdroj: Human Genomics, 14, 1
Human Genomics, 14
Human Genomics
Human Genomics, Vol 14, Iss 1, Pp 1-10 (2020)
ISSN: 1479-7364
1473-9542
Popis: Background Mitochondrial diseases (MDs) are a group of clinically and genetically heterogeneous disorders characterized by defects in oxidative phosphorylation. Since clinical phenotypes of MDs may be non-specific, genetic diagnosis is crucial for guiding disease management. In the current study, whole-exome sequencing (WES) was performed for our paediatric-onset MD cohort of a Southern Chinese origin, with the aim of identifying key disease-causing variants in the Chinese patients with MDs. Methods We recruited Chinese patients who had paediatric-onset MDs and a minimum mitochondrial disease criteria (MDC) score of 3. Patients with positive target gene or mitochondrial DNA sequencing results were excluded. WES was performed, variants with population frequency ≤ 1% were analysed for pathogenicity on the basis of the American College of Medical Genetics and Genomics guidelines. Results Sixty-six patients with pre-biopsy MDC scores of 3–8 were recruited. The overall diagnostic yield was 35% (23/66). Eleven patients (17%) were found to have mutations in MD-related genes, with COQ4 having the highest mutation rate owing to the Chinese-specific founder mutation (4/66, 6%). Twelve patients (12/66, 18%) had mutations in non-MD-related genes: ATP1A3 (n = 3, two were siblings), ALDH5A1, ARX, FA2H, KCNT1, LDHD, NEFL, NKX2-2, TBCK, and WAC. Conclusions We confirmed that the COQ4:c.370G>A, p.(Gly124Ser) variant, was a founder mutation among the Southern Chinese population. Screening for this mutation should therefore be considered while diagnosing Chinese patients suspected to have MDs. Furthermore, WES has proven to be useful in detecting variants in patients suspected to have MDs because it helps to obtain an unbiased and precise genetic diagnosis for these diseases, which are genetically heterogeneous.
Databáze: OpenAIRE